Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer Therapies
Status:
Not yet recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
It is important for patients treated with anti-EGFR therapies to get access to cosmetic
options to preserve their skin condition during treatment. Anti-EGFR therapies are known to
fragilize epidermis and to provoke rashes; which often lead to treatment discontinuation.
The aim of this study is to demonstrate that the Onco-Rash cream is able to preserve skin
condition without side effects. Decreasing skin toxicity is expected to improve patients'
life and facilitate treatment follow-up.